Serine protease inhibitors inhibit superoxide production by human basophils stimulated by anti-IgE.
D000888:Antibodies, Anti-Idiotypic / Q000494:pharmacology*; D001491:Basophils / Q000187:drug effects / Q000378:metabolism*; D003574:Cytochrome c Group; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology* / Q000494:pharmacology; D007700:Kinetics; D010100:Oxygen / Q000097:blood*; D011480:Protease Inhibitors / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D013482:Superoxide Dismutase; D013481:Superoxides / Q000097:blood*
D000888:Antibodies, Anti-Idiotypic; D003574:Cytochrome c Group; D011480:Protease Inhibitors; C026408:anti-IgE antibodies; D013481:Superoxides; D007073:Immunoglobulin E; D013482:Superoxide Dismutase; D010100:Oxygen